search
view_module view_stream
S-allylcysteine for Use in the Prevention and Treatment of Plasma Cell Dyscrasias
Technology No. ORL01-32
S-allylcysteine for Use in the Prevention and Treatment of Plasma Cell Dyscrasias
Find out more
Selective KRAS(G12D)-Binding Monobodies for the Treatment of Cancer
Technology No. KOI01-07
Selective KRAS(G12D)-Binding Monobodies for the Treatment of Cancer
Find out more
Pre-Vetted Transactions Only (SOM)
Technology No.
Pre-Vetted Transactions Only (SOM)
Find out more
SCRATCH-seq: Capturing Dynamic Genetic Changes in Lymphocytes
Technology No. KOR01-06
SCRATCH-seq: Capturing Dynamic Genetic Changes in Lymphocytes
Find out more
Selective NRAS-Binding Monobodies for the Treatment of Cancer
Technology No. KOI01-10
Selective NRAS-Binding Monobodies for the Treatment of Cancer
Find out more
Monodisperse PVT Spheres
Technology No. PVT SPHERES
Monodisperse PVT Spheres
Find out more
Topical Inhibition of HIF-1a as a Novel Therapeutic Strategy for Inflammatory Skin Diseases
Technology No. NAI02-3
Topical Inhibition of HIF-1a as a Novel Therapeutic Strategy for Inflammatory Skin Diseases
Find out more
Catalysts to Efficiently Convert Lignin Biomass to Valuable and Sustainable Chemicals
Technology No. DIA01-01
Catalysts to Efficiently Convert Lignin Biomass to Valuable and Sustainable Chemicals
Find out more
Monodisperse PS Spheres
Technology No. PS Spheres
Monodisperse PS Spheres
Find out more
Epitranscriptomic Modulation of Type I IFN Pathway to Treat Cancer and Autoimmune, Inflammatory, and Infectious Diseases
Technology No. MOH02-07
Epitranscriptomic Modulation of Type I IFN Pathway to Treat Cancer and Autoimmune, Inflammatory, and Infectious Diseases
Find out more
NYU adVANCE Software
Technology No. MOR04-01
NYU adVANCE Software
Find out more
miRNA-Mediated Transgene Expression System for Improved Gene Therapies and Research Reagent Applications
Technology No. TEN01-04
miRNA-Mediated Transgene Expression System for Improved Gene Therapies and Research Reagent Applications
Find out more
Clinical Prognostic Models for Stage II Melanoma Using Tumor miRNA Signatures
Technology No. POL01-05
Clinical Prognostic Models for Stage II Melanoma Using Tumor miRNA Signatures
Find out more
Multivalent Assembled Proteins (MAPs): Therapeutics for Cancer and Infectious Diseases
Technology No. MON02-11
Multivalent Assembled Proteins (MAPs): Therapeutics for Cancer and Infectious Diseases
Find out more
Aryl-Diazonium Analogues as Potent DNA Cleavage Agents for Treating Cancer and Bacterial Infections
Technology No. DIA01-02
Aryl-Diazonium Analogues as Potent DNA Cleavage Agents for Treating Cancer and Bacterial Infections
Find out more
Transcription-Associated Cas9 Targeting in Eukaryotic Cells
Technology No. BOE01-20
Transcription-Associated Cas9 Targeting in Eukaryotic Cells
Find out more
Chip-based Prognostic Tool for Improved Leukemia Treatment Outcomes
Technology No. CHE11-02
Chip-based Prognostic Tool for Improved Leukemia Treatment Outcomes
Find out more
Drug Targets for Overcoming Resistance to KRAS G12C Inhibitors (G12Cis) in Cancer
Technology No. NEE02-05
Drug Targets for Overcoming Resistance to KRAS G12C Inhibitors (G12Cis) in Cancer
Find out more
Novel Probiotic Compositions for Improving Metabolism and Immunity
Technology No. BLA02-12
Novel Probiotic Compositions for Improving Metabolism and Immunity
Find out more
Novel Class of Anthelmintic Compounds and Proprietary Screening Method for Anthelmintic Discovery
Technology No. PIA01-02
Novel Class of Anthelmintic Compounds and Proprietary Screening Method for Anthelmintic Discovery
Find out more
Therapeutic Hyaluronic Acid and Peptide Composition for Regenerative Repair of Cartilage Injury
Technology No. COW02-02
Therapeutic Hyaluronic Acid and Peptide Composition for Regenerative Repair of Cartilage Injury
Find out more
Never Look Away Training Seminar, January-March 2024
Technology No. NLA
Never Look Away Training Seminar, January-March 2024
Find out more
Injectable Therapeutic Hydrogel for the Treatment of Post-Traumatic Osteoarthritis
Technology No. LIU02-02, MON02-04
Injectable Therapeutic Hydrogel for the Treatment of Post-Traumatic Osteoarthritis
Find out more
Hydrophobically Interspaced, Charged Peptides for the Treatment and Prevention of Dementia
Technology No. WIS02-26
Hydrophobically Interspaced, Charged Peptides for the Treatment and Prevention of Dementia
Find out more
Anti-CD97 Antibody-Drug Conjugates for the Treatment of AML and GBM
Technology No. KOI01-16
Anti-CD97 Antibody-Drug Conjugates for the Treatment of AML and GBM
Find out more
Biomarkers of Severe and Cerebral Malaria
Technology No. ROD01-18
Biomarkers of Severe and Cerebral Malaria
Find out more
Salt-Inducible Kinase Activators to Treat Bone and Mineral Diseases
Technology No. PAR07-01
Salt-Inducible Kinase Activators to Treat Bone and Mineral Diseases
Find out more
High-Throughput Design and Engineering of Mammalian Cells
Technology No. TRO02-01
High-Throughput Design and Engineering of Mammalian Cells
Find out more
Ultrasonic Probe Device and System and Methods for Generating Ultrasonic Images
Technology No. TSU02-01
Ultrasonic Probe Device and System and Methods for Generating Ultrasonic Images
Find out more
Device for the Treatment of Lower Extremity Deep Vein Thrombosis
Technology No. GAR05-01
Device for the Treatment of Lower Extremity Deep Vein Thrombosis
Find out more
ParentCorps (Friends School, Continuing Sites Only)
Technology No.
ParentCorps (Friends School, Continuing Sites Only)
Find out more
Small Molecule Inhibitors of SPNS2 for the Treatment of Chronic Inflammatory Diseases
Technology No. SCH14-01
Small Molecule Inhibitors of SPNS2 for the Treatment of Chronic Inflammatory Diseases
Find out more
Screening Method and Gene Therapy Approach for Treating Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D)
Technology No. DEL05-02
Screening Method and Gene Therapy Approach for Treating Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D)
Find out more
Methods of Sensitizing Estrogen Receptor-Positive Breast Cancer to Endocrine Therapy
Technology No. SCH03-09
Methods of Sensitizing Estrogen Receptor-Positive Breast Cancer to Endocrine Therapy
Find out more
Genetic System to Selectively Generate Single-Sex Chickens
Technology No. DAV06-04
Genetic System to Selectively Generate Single-Sex Chickens
Find out more
ParentCorps (Parenting Program, Continuing Sites Only)
Technology No.
ParentCorps (Parenting Program, Continuing Sites Only)
Find out more
Pre-Vetted Transactions Only (WSQ)
Technology No.
Pre-Vetted Transactions Only (WSQ)
Find out more
ASRS DSM-5
Technology No. ADL01-06
ASRS DSM-5
Find out more
Apolipoprotein B Peptide Mimics for Atherosclerosis Treatment
Technology No. GOL05-04
Apolipoprotein B Peptide Mimics for Atherosclerosis Treatment
Find out more
Efficient and High-Throughput Tool to Engineer Aligned 3D Collagen Matrices for Tissue Culture
Technology No. TEO01-01
Efficient and High-Throughput Tool to Engineer Aligned 3D Collagen Matrices for Tissue Culture
Find out more
Targeting Endocytosis in Nociceptors as a Non-Opioid Treatment Strategy for Chronic Pain
Technology No. BUN01-01
Targeting Endocytosis in Nociceptors as a Non-Opioid Treatment Strategy for Chronic Pain
Find out more
IL-17 Receptor Modulator Screen
Technology No. LIT01-52
IL-17 Receptor Modulator Screen
Find out more
Treatment of Melanoma Brain Metastasis by Inhibition of Amyloid Precursor Protein Cleavage
Technology No. HER02-07
Treatment of Melanoma Brain Metastasis by Inhibition of Amyloid Precursor Protein Cleavage
Find out more
Method of Treating Lung Cancer in Patients with LKB1 Genetically-Inactivated Tumors
Technology No. WON02-07
Method of Treating Lung Cancer in Patients with LKB1 Genetically-Inactivated Tumors
Find out more
Vectored ACE2 Receptor Decoy for Prevention and Treatment of Pan-Coronavirus Infections
Technology No. LAN02-06
Vectored ACE2 Receptor Decoy for Prevention and Treatment of Pan-Coronavirus Infections
Find out more
Nanobodies Targeting SARS-CoV-2 NSP9 for COVID Treatment
Technology No. PER03-04
Nanobodies Targeting SARS-CoV-2 NSP9 for COVID Treatment
Find out more
Saliva-Based Cytokine Score to Predict the Severity of Clinical Periodontal Inflammation
Technology No. KAM01-01
Saliva-Based Cytokine Score to Predict the Severity of Clinical Periodontal Inflammation
Find out more
CD11c-DTR Transgenic Mice (B6.FVB-1700016L21RikTg [Itgax-DTR/EGFP] 57Lan/J; Jax stock number: 004509 )
Technology No. LIT01-08
CD11c-DTR Transgenic Mice (B6.FVB-1700016L21RikTg [Itgax-DTR/EGFP] 57Lan/J; Jax stock number: 004509 )
Find out more
TET2 Conditional Knockout Transgenic Mice
Technology No. AIF01-14
TET2 Conditional Knockout Transgenic Mice
Find out more
Human Immunodeficiency Virus 1 (HIV-1) NL4-3 ΔEnv Vpr Luciferase Reporter Vector (pNL4-3.Luc.R-E-)
Technology No. LAN02-04
Human Immunodeficiency Virus 1 (HIV-1) NL4-3 ΔEnv Vpr Luciferase Reporter Vector (pNL4-3.Luc.R-E-)
Find out more
CHIIMERAâ„¢ 3D Anatomy Education Software
Technology No. TRI01-01
CHIIMERAâ„¢ 3D Anatomy Education Software
Find out more
iScore: A Novel Method for Improved Risk Stratification of AML Patients
Technology No. AIF01-12
iScore: A Novel Method for Improved Risk Stratification of AML Patients
Find out more
Monodisperse PMMA Spheres
Technology No. PMMA SPHERES
Monodisperse PMMA Spheres
Find out more
Novel Targets for Cancer Therapy
Technology No. WON02-04
Novel Targets for Cancer Therapy
Find out more
Identification of Zinc Fingers and Their DNA Targets
Technology No. NOY01-01
Identification of Zinc Fingers and Their DNA Targets
Find out more
AutoCharge: Fully Autonomous, High-efficiency Charging for Quadcopters and Other Autonomous Vehicles
Technology No. LOI01-02
AutoCharge: Fully Autonomous, High-efficiency Charging for Quadcopters and Other Autonomous Vehicles
Find out more
Colo-Cleanse: Colonic Irrigation Solution
Technology No. POC01-01
Colo-Cleanse: Colonic Irrigation Solution
Find out more
Novel Method for Labeling Cells and Living Animals with Isotopically Label Gases
Technology No. PAC02-01
Novel Method for Labeling Cells and Living Animals with Isotopically Label Gases
Find out more
Tau Kinase Inhibitor for Preventing or Treating Glucocorticoid-Induced Osteoporosis
Technology No. LIU02-10
Tau Kinase Inhibitor for Preventing or Treating Glucocorticoid-Induced Osteoporosis
Find out more
Novel Enzyme in CoQ10 Biosynthesis Pathway as a Novel Target to Treat Pancreatic Ductal Adenocarcinoma
Technology No. PAC02-01
Novel Enzyme in CoQ10 Biosynthesis Pathway as a Novel Target to Treat Pancreatic Ductal Adenocarcinoma
Find out more
Treatment for Alzheimer’s Disease by Inhibiting Formation of Platelet Micro-Clots
Technology No. WIS02-24
Treatment for Alzheimer’s Disease by Inhibiting Formation of Platelet Micro-Clots
Find out more
Antibody-Based Inhibitors of the Staphylococcus aureus Multidrug Efflux Pump NorA
Technology No. KOI01-06
Antibody-Based Inhibitors of the Staphylococcus aureus Multidrug Efflux Pump NorA
Find out more
Osteoarthritis (OA) Biomarker Suitable as a Point-of-Care Diagnostic
Technology No. WIS01-03
Osteoarthritis (OA) Biomarker Suitable as a Point-of-Care Diagnostic
Find out more
Novel Biomarker Predicting Response to Checkpoint Inhibitor Therapy in Metastatic Melanoma
Technology No. KIR03-02
Novel Biomarker Predicting Response to Checkpoint Inhibitor Therapy in Metastatic Melanoma
Find out more
Methods of Treating Cancers Having a Deregulated Metabolic Pathway
Technology No. PAP02-01
Methods of Treating Cancers Having a Deregulated Metabolic Pathway
Find out more
A Novel Small Molecule PABA Derivative C45-NA Enhances Anti-Tumor Activity
Technology No. BRO02-03
A Novel Small Molecule PABA Derivative C45-NA Enhances Anti-Tumor Activity
Find out more
Therapeutic Targeting of KMT2D Mutant Lung Cancer Via RTK-RAS Signaling Inhibition
Technology No. WON02-05
Therapeutic Targeting of KMT2D Mutant Lung Cancer Via RTK-RAS Signaling Inhibition
Find out more
Novel, Non-Staining Filling for Minimally-Invasive Treatment of Dental Caries
Technology No. WAL03-10
Novel, Non-Staining Filling for Minimally-Invasive Treatment of Dental Caries
Find out more
Targeting the SARS-CoV-2 Viral-Immune Interaction for COVID-19 Therapy
Technology No. WAN05-01
Targeting the SARS-CoV-2 Viral-Immune Interaction for COVID-19 Therapy
Find out more
Viral Vector Expression of Gabrb1b for the Treatment of Perceptual Deficits
Technology No. SAN06-01
Viral Vector Expression of Gabrb1b for the Treatment of Perceptual Deficits
Find out more
Novel miRNA and Protein Therapeutic Targets to Reduce Atherosclerosis
Technology No. HUS02-04
Novel miRNA and Protein Therapeutic Targets to Reduce Atherosclerosis
Find out more
Steroid Modulators of Treg Lymphocytes and Pro-Inflammatory T Helper Cells For Autoimmune Disease
Technology No. LIT01-13
Steroid Modulators of Treg Lymphocytes and Pro-Inflammatory T Helper Cells For Autoimmune Disease
Find out more
Targeting a Novel Metabolic Network for Pancreatic Ductal Adenocarcinoma (PDAC) Treatment
Technology No. KIM06-01
Targeting a Novel Metabolic Network for Pancreatic Ductal Adenocarcinoma (PDAC) Treatment
Find out more
Paper-Based, Multiplexed Lamp Diagnostic for Pathogen Detection
Technology No. QAS01-09
Paper-Based, Multiplexed Lamp Diagnostic for Pathogen Detection
Find out more
Engineered Progranulin: A Promising Therapeutic Approach for Autoimmune Diseases
Technology No. LIU02-03
Engineered Progranulin: A Promising Therapeutic Approach for Autoimmune Diseases
Find out more
PHOTACS: Photo-Activatable PROTACS
Technology No. TRA03-01
PHOTACS: Photo-Activatable PROTACS
Find out more
Peptidomimetic-Steroid Conjugates for Castration-Resistant Prostate Cancer (CRPC) Treatment
Technology No. KIR01-10
Peptidomimetic-Steroid Conjugates for Castration-Resistant Prostate Cancer (CRPC) Treatment
Find out more
Netrin-1 and UNC5B as Novel Targets in Metabolic Liver Diseases: NAFLD & NASH
Technology No. MOO02-06
Netrin-1 and UNC5B as Novel Targets in Metabolic Liver Diseases: NAFLD & NASH
Find out more
KaryoCreate (Karyotype CRISPR Engineered Aneuploidy Technology)
Technology No. DAV06-02
KaryoCreate (Karyotype CRISPR Engineered Aneuploidy Technology)
Find out more
FGF23 Ligand Trap: New Biologic for Treating Kidney Diseases
Technology No. MOH01-02
FGF23 Ligand Trap: New Biologic for Treating Kidney Diseases
Find out more
Chimeric FGF21: Treatment of NAFLD, NASH and Hepatic Steatosis
Technology No. MOH01-03
Chimeric FGF21: Treatment of NAFLD, NASH and Hepatic Steatosis
Find out more
ASRS v1.1 18-Question Symptom Checklist
Technology No. ADL01-07
ASRS v1.1 18-Question Symptom Checklist
Find out more
Adhesive Bandage for Rapid Pathogen Immune Response Detection
Technology No. QAS01-09
Adhesive Bandage for Rapid Pathogen Immune Response Detection
Find out more
Angiotensin-Converting Enzyme 2 (ACE2) Immunoadhesin Microbody
Technology No. LAN02-03
Angiotensin-Converting Enzyme 2 (ACE2) Immunoadhesin Microbody
Find out more
Nano Zeolite-Y: A Novel and Cost-Effective Antibacterial Composition
Technology No. ANI01-01
Nano Zeolite-Y: A Novel and Cost-Effective Antibacterial Composition
Find out more
Novel Lumican-Binding Peptides Acting on the Toll-Like Receptor Pathway in Inflammation and Related Conditions
Technology No. CHA10-02
Novel Lumican-Binding Peptides Acting on the Toll-Like Receptor Pathway in Inflammation and Related Conditions
Find out more
Targeting RNA Viruses Using Inhibitors of METTL3
Technology No. MOH02-08
Targeting RNA Viruses Using Inhibitors of METTL3
Find out more
ASOs Targeting CHROMR for the Treatment of Inflammatory Diseases
Technology No. MOO02-07
ASOs Targeting CHROMR for the Treatment of Inflammatory Diseases
Find out more
Novel Enzyme in CoQ10 Biosynthesis Pathway as a Novel Target to Treat Neurological Diseases
Technology No. PAC02-02
Novel Enzyme in CoQ10 Biosynthesis Pathway as a Novel Target to Treat Neurological Diseases
Find out more
PKP2cKO Transgenic Mouse Model
Technology No. DEL05-01
PKP2cKO Transgenic Mouse Model
Find out more
Anti-CD99 Antibodies Cytotoxic to Leukemia
Technology No. KOI01-05
Anti-CD99 Antibodies Cytotoxic to Leukemia
Find out more
Oral Insulin Delivery Nanoparticles for Diabetes Treatment
Technology No. TRA02-04
Oral Insulin Delivery Nanoparticles for Diabetes Treatment
Find out more
Photoactivatable Lipid Nanoparticles for Drug Delivery
Technology No. TRA03-04
Photoactivatable Lipid Nanoparticles for Drug Delivery
Find out more
TET2 Modulators for the Treatment of Cancer and Inflammatory Diseases
Technology No. AIF01-09
TET2 Modulators for the Treatment of Cancer and Inflammatory Diseases
Find out more
Small Molecule Antagonist of the RAGE-DIAPH1 Signaling Axis for Diabetic Kidney Disease (DKD) Treatment
Technology No. SCH08-06
Small Molecule Antagonist of the RAGE-DIAPH1 Signaling Axis for Diabetic Kidney Disease (DKD) Treatment
Find out more
Novel Biomarkers for Detection and Treatment of Immune Deficiencies During Pregnancy
Technology No. HAN04-01
Novel Biomarkers for Detection and Treatment of Immune Deficiencies During Pregnancy
Find out more
Smart Braces
Technology No. TEI01-04
Smart Braces
Find out more
Novel Wound Healing Hydrogels
Technology No. RAB02-02
Novel Wound Healing Hydrogels
Find out more
Non-Antibiotic Treatment of Staphylococcal Infections
Technology No. NOV01-14
Non-Antibiotic Treatment of Staphylococcal Infections
Find out more
Endock: Docking Station for Medical Instruments
Technology No. MON04-01
Endock: Docking Station for Medical Instruments
Find out more
Succinate Receptor 1 (SUCNR1) Antagonists to Treat Neuroinflammation
Technology No. LI06-03
Succinate Receptor 1 (SUCNR1) Antagonists to Treat Neuroinflammation
Find out more
Avobenzone-Dendrimer Conjugates
Technology No. WEC01-04
Avobenzone-Dendrimer Conjugates
Find out more
A Method for Treating Autoimmune Disease Exacerbated by Host Immune Response to Commensal Bacteria
Technology No. SIL02-05
A Method for Treating Autoimmune Disease Exacerbated by Host Immune Response to Commensal Bacteria
Find out more
NSP14/10 Complex Inhibitors for the Treatment of SARS-CoV-2 and Pan-Coronavirus Infections
Technology No. PAG01-15
NSP14/10 Complex Inhibitors for the Treatment of SARS-CoV-2 and Pan-Coronavirus Infections
Find out more
Targeting Mutant NT5C2 in Relapsing Acute Lymphoblastic Leukemia
Technology No. CAR01-02
Targeting Mutant NT5C2 in Relapsing Acute Lymphoblastic Leukemia
Find out more
Single-Domain Antibodies (sdAbs) Against Tau and A-syn as Therapeutic and Diagnostic Tools for Neurodegenerative Diseases
Technology No. SIG01-12
Single-Domain Antibodies (sdAbs) Against Tau and A-syn as Therapeutic and Diagnostic Tools for Neurodegenerative Diseases
Find out more
Video-Enabled, AI-Based Fire Detection
Technology No. PAN01-05
Video-Enabled, AI-Based Fire Detection
Find out more
Novel MicroRNA-30c Analogs to Reduce Secretion of Apolipoprotein B in Human Hepatoma Cells
Technology No. HUS02-03
Novel MicroRNA-30c Analogs to Reduce Secretion of Apolipoprotein B in Human Hepatoma Cells
Find out more
A Novel Blood Marker for Prognostication and Treatment of Non-Small Cell Lung Cancer
Technology No. PAS02-13
A Novel Blood Marker for Prognostication and Treatment of Non-Small Cell Lung Cancer
Find out more
Transgenic Mouse Model Expressing C217G Uromodulin
Technology No. WU01-01
Transgenic Mouse Model Expressing C217G Uromodulin
Find out more
Category
chevron_right
chevron_right
chevron_right
chevron_right
chevron_right
chevron_right
chevron_right